2003
DOI: 10.1289/ehp.6205
|View full text |Cite
|
Sign up to set email alerts
|

Comparable measures of cognitive function in human infants and laboratory animals to identify environmental health risks to children.

Abstract: The importance of including neurodevelopmental end points in environmental studies is clear. A validated measure of cognitive function in human infants that also has a homologous or parallel test in laboratory animal studies will provide a valuable approach for large-scale studies. Such a comparable test will allow researchers to observe the effect of environmental neurotoxicants in animals and relate those findings to humans. In this article, we present the results of a review of post-1990, peerreviewed liter… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
4
0
1

Year Published

2005
2005
2021
2021

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(5 citation statements)
references
References 102 publications
0
4
0
1
Order By: Relevance
“…The rodent tests for neurobehavioral assessment used in the animal studies were designed to measure similar functions as neurobehavioral tests conducted for humans but they cannot match the complexity of human behavior (Ulbrich and Palmer, 1996). The test batteries include tests of locomotor activity and crude assessments of learning, sensory, and motor integration, and these are typically parallel tests, in that they are conducted in a different manner in humans but it is believed that the same functions are being measured (Sharbaugh et al, 2003). Ideally, homologous tests, which follow the same procedure in both animals and humans, would provide a more accurate measure of the same cognitive function, but such tests are not available (Sharbaugh et al, 2003).…”
Section: Evaluation Of Hypotheses For All Lines Of Evidence Togethermentioning
confidence: 99%
See 1 more Smart Citation
“…The rodent tests for neurobehavioral assessment used in the animal studies were designed to measure similar functions as neurobehavioral tests conducted for humans but they cannot match the complexity of human behavior (Ulbrich and Palmer, 1996). The test batteries include tests of locomotor activity and crude assessments of learning, sensory, and motor integration, and these are typically parallel tests, in that they are conducted in a different manner in humans but it is believed that the same functions are being measured (Sharbaugh et al, 2003). Ideally, homologous tests, which follow the same procedure in both animals and humans, would provide a more accurate measure of the same cognitive function, but such tests are not available (Sharbaugh et al, 2003).…”
Section: Evaluation Of Hypotheses For All Lines Of Evidence Togethermentioning
confidence: 99%
“…The test batteries include tests of locomotor activity and crude assessments of learning, sensory, and motor integration, and these are typically parallel tests, in that they are conducted in a different manner in humans but it is believed that the same functions are being measured (Sharbaugh et al, 2003). Ideally, homologous tests, which follow the same procedure in both animals and humans, would provide a more accurate measure of the same cognitive function, but such tests are not available (Sharbaugh et al, 2003). For example, although a common endpoint for children is a score on a standardized test of intelligence or IQ, there are no standardized intelligence tests for animals that can identify subtle cognitive dysfunction (Rice, 2005;Winneke, 1992).…”
Section: Evaluation Of Hypotheses For All Lines Of Evidence Togethermentioning
confidence: 99%
“…As in other diseases, properly conducted animal models may be useful in the search for preventive measures or a cure for AD. The development of animal models with cognitive profiles and pathological changes similar to those seen in humans with AD is the goal of translational research (Sharbaugh et al, 2003). Such models could be used in preclinical studies assessing the potential of novel therapeutics.…”
Section: Animal Models Of Admentioning
confidence: 99%
“…Planning for this large study began in mid-2000 with the initiation of a number of methods development studies, particularly the development of less burdensome and less costly exposure assessment methods ( U.S. EPA 2004a ). Other efforts have included laboratory studies on noninvasive procedures for analysis of biomarkers of exposures and outcomes ( Rockett et al 2002 ), development of comparable measures that could be administered in children and laboratory animal models enabling further exploration of exposure–outcome links in animal studies ( Sharbaugh et al 2003 ), and field studies using focus groups to explore recruitment and retention issues. A number of reviews and white papers have been developed, including an evaluation of advanced technology for capturing data, a review of the leading hypotheses of the effects of environmental factors on children’s health outcomes, and a review of the leading sampling strategies for consideration in the study.…”
Section: The National Children’s Studymentioning
confidence: 99%